Whilst restrictions are being lifted in most public places on 19 July 2021, strict Infection Control needs to be followed in hospitals and healthcare settings, to stop vulnerable people from being placed at additional risk.
Patients and Visitors |
COVID-19 Vaccination and Testing Coming to the hospital: appointments and visiting patients
|
|
Staff |
||
A network of Sub Regional Advisory Panels (SRIAPs) was created by NHS England in 2018 to manage immunoglobulin usage by ensuring it is only used in accordance with national guidelines, as developed by an expert consensus group drawn from across the UK.
The Peninsula SRIAP was set up to cover the activity of the five NHS Trusts across Devon and Cornwall. The panel membership was drawn from across the five Trusts in the peninsula. All treatment with immunoglobulins is subject to review or authorisation by the Panel.
Trusts signed up to oversight by the Peninsula SRIAP are:
The panel meets every two weeks and consists of a Panel Chair, NHS England Commissioner, Neurologist, Immunologist, Haematologist, Specialist Immunology Nurse, SRIAP Data Performance Manager, also Pharmacists and Blood Bank Managers from respective Trusts.
Clinical Requests
Applications for treatment with immunoglobulin require a completed Immunoglobulin Clinical Approval Request form prior to treatment (± funding authorisation, depending on the condition to be treated). Completed form needs to be submitted no later than 6 days prior to next scheduled panel meeting.
Replacement long term application form (2).
